HOME >> BIOLOGY >> NEWS
Stanford launches interdisciplinary initiative in the biological sciences

s and engineers would be randomly located throughout the space to facilitate serendipitous encounters.

Although funding, plans and permits must be obtained before ground can be broken on the building, the first manifestation of the Bio-X program will appear next fall with the course "Frontiers in Interdisciplinary Biosciences." It will be taught every quarter and has been assigned the course number 459 in a number of departments from all three schools: Engineering, Medicine, and Humanities and Sciences.

The course will consist of three seminars per quarter, and lecturers will be internationally renowned researchers whose work is distinguished by interaction between the life sciences and other disciplines. What sets the new course apart is the fact that students will meet prior to each seminar for a one- to two-hour tutorial that will be designed to ?level the playing field? among students from different disciplines.

"This turns the seminars into real teaching tools, and will show the students that Bio-X is a serious enterprise," says Robertson.

"The success of Bio-X must come from the faculty and it has to stay with the faculty," adds William Mobley, the John E. Cahill Family Professor and chair of neurology, and a member of the Bio-X executive committee.

"In biology, to make something go faster, you have to raise the concentration of one of the reagents. In Bio-X, we are raising the concentration of all the reagents, so the program is biologically defensible!"


'"/>

Contact: David F. Salisbury
salisbury@stanford.edu
650-725-1944
Stanford University
9-Jun-1999


Page: 1 2 3 4 5 6 7

Related biology news :

1. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
2. Stanford researchers findings may shed light on common, deadly birth defect
3. Leukemia stem cells identified by Stanford researchers
4. New view of leukemia cells identifies best treatment options, Stanford researchers say
5. Confidentiality of genetic databases questioned by Stanford researchers
6. Stanford researchers go from heaven to Earth in lifeguard test
7. Transplant rejection averted by simple light exposure in Stanford animal study
8. Fat cells heal skull defects in mice, Stanford research shows
9. Gene-based screen sorts cancer cases, say Stanford researchers
10. Elusive but ubiquitous microbe fingered as gum disease culprit in Stanford study
11. Sticklebacks reveal secrets to evolutionary change in Stanford study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2016)... 16, 2016   EyeLock LLC , a market ... opening of an IoT Center of Excellence in ... the development of embedded iris biometric applications. ... convenience and security with unmatched biometric accuracy, making it ... from DNA. EyeLock,s platform uses video technology to deliver ...
(Date:4/28/2016)... SAN FRANCISCO and BANGALORE, India ... part of EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... service provider, today announced a global partnership that ... convenient way to use mobile banking and payment services. ... Mobility is a key innovation area for financial services, but ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample tracking software ... State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. , ... Tremblay, President and COO of STACS DNA. “In further expanding our capacity as a ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... & Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... Review , the peer-reviewed journal from touchONCOLOGY, ... the escalating cost of cancer care is placing ... a result of expensive biologic therapies. With the ...
Breaking Biology Technology:
Cached News: